These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2196493)

  • 21. Central fetal monitoring: effect on perinatal outcomes and cesarean section rate.
    Withiam-Leitch M; Shelton J; Fleming E
    Birth; 2006 Dec; 33(4):284-8. PubMed ID: 17150066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaginal birth after Cesarean delivery: predicting success, risks of failure.
    Durnwald C; Mercer B
    J Matern Fetal Neonatal Med; 2004 Jun; 15(6):388-93. PubMed ID: 15280110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intervals for increasing the dosage of oxytocin].
    Adelwöhrer NE; Rollett H; Haas J; Auner J
    Zentralbl Gynakol; 1993; 115(9):396-9. PubMed ID: 8237158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Labour in patients with a caesarean section scar. The place of oxytocin augmentation.
    van Gelderen CJ; England MJ; Naylor GA; Katzeff TC
    S Afr Med J; 1986 Oct; 70(9):529-32. PubMed ID: 3775598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of uterine activity by ambulatory tocography].
    Crenn-Hébert C; Chave C; Monclin H; Tournaire M
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(8):1027-32. PubMed ID: 2081864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of uterine activity using the Term Guard monitor versus standard external tocodynamometry compared with the intrauterine pressure catheter.
    Hess LW; McCaul JF; Perry KG; Howard PR; Morrison JC
    Obstet Gynecol; 1990 Jul; 76(1 Suppl):52S-55S. PubMed ID: 2359580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of uterine hyperstimulation with concomitant use of oxytocin and terbutaline.
    Pacheco LD; Rosen MP; Gei AF; Saade GR; Hankins GD
    Am J Perinatol; 2006 Aug; 23(6):377-80. PubMed ID: 16847795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prediction of "controlled" uterine rupture by the use of intrauterine pressure catheters.
    Devoe LD; Croom CS; Youssef AA; Murray C
    Obstet Gynecol; 1992 Oct; 80(4):626-9. PubMed ID: 1407884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Currently used oxytocin regimen outcome measures at term & postterm. I: Outcome indicators in relation to parity & indication for induction.
    Berhan Y; Dwivedi AD
    Ethiop Med J; 2007 Jul; 45(3):235-42. PubMed ID: 18330323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Misoprostol--a PGE1 analog for induction of labor at term: comparative and randomized study with oxytocin].
    Campos GA; Guzmán S; Rodríguez JG; Voto LS; Margulies M
    Rev Chil Obstet Ginecol; 1994; 59(3):190-5; discussion 195-6. PubMed ID: 7659811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of measured external tocodynamometry with measured internal uterine activity.
    Paul MJ; Smeltzer JS
    Am J Perinatol; 1991 Nov; 8(6):417-20. PubMed ID: 1814307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose oxytocin: 20- versus 40-minute dosage interval.
    Satin AJ; Leveno KJ; Sherman ML; McIntire D
    Obstet Gynecol; 1994 Feb; 83(2):234-8. PubMed ID: 8290186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of labor with 50 and 100 microg of misoprostol: comparison of maternal and fetal outcomes.
    Ozsoy M; Ozsoy D
    Eur J Obstet Gynecol Reprod Biol; 2004 Mar; 113(1):41-4. PubMed ID: 15036709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxytocin-induced labor characteristics and uterine activity after preinduction cervical priming with prostaglandin E2 intracervical gel.
    Ferguson JE; Ueland FR; Stevenson DK; Ueland K
    Obstet Gynecol; 1988 Nov; 72(5):739-45. PubMed ID: 3173925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective comparison of hourly and quarter-hourly oxytocin dose increase intervals for the induction of labor at term.
    Blakemore KJ; Qin NG; Petrie RH; Paine LL
    Obstet Gynecol; 1990 May; 75(5):757-61. PubMed ID: 2325960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial.
    Meyer M; Pflum J; Howard D
    Obstet Gynecol; 2005 Mar; 105(3):466-72. PubMed ID: 15738009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double blind, randomized trial on augmentation of labour with a combination of intravenous propranolol and oxytocin versus oxytocin only.
    Palomäki O; Uotila J; Tammela O; Kaila T; Lavapuro M; Huhtala H; Tuimala R
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):44-9. PubMed ID: 16051416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High- versus low-dose oxytocin for augmentation or induction of labor.
    Patka JH; Lodolce AE; Johnston AK
    Ann Pharmacother; 2005 Jan; 39(1):95-101. PubMed ID: 15572602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome in obstetric care related to oxytocin use. A population-based study.
    Oscarsson ME; Amer-Wåhlin I; Rydhstroem H; Källén K
    Acta Obstet Gynecol Scand; 2006; 85(9):1094-8. PubMed ID: 16929414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of uterine contraction curve registered by external tocography in imminent premature delivery with tocolytic treatment being given special consideration].
    Torbé A
    Ann Acad Med Stetin; 1993; 39():167-83. PubMed ID: 8154617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.